Tech Company Financing Transactions
Beta Bionics Funding Round
Beta Bionics, based in Boston, secured $50.8 thousand from private investors.
Transaction Overview
Company Name
Announced On
5/18/2016
Transaction Type
Online Capital
Online Capital
Online Capital
Amount
$50,765
Round
Undisclosed
Investors
private investors (Enrique Conterno)
Proceeds Purpose
Proceeds purposes were not disclosed. Transaction amount may include investment reservation only or amount actually remitted to company. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
8 Saint Mary's St. 936
Boston, MA 02215
USA
Boston, MA 02215
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Beta Bionics is proud to be a Massachusetts public benefit corporation. We believe we are one of the first, if not the first medical device company to be doing business as a benefit corporation, and we're fairly certain that Beta Bionics is the first company to do so in the diabetes space.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Edward Damiano
Vice President
Firas El-Khatib
VP - Bus. Development
Ed Raskin
VP - General Counsel
Serafina Raskin
VP - Operations
David Henderson
VP - R & D
Michael Rosinko
Browse more venture capital transactions:
Prev: 5/18/2016: Scilex Pharmaceuticals venture capital transaction
Next: 5/18/2016: Agenovir venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs